Manchester Eye and Cosmetic Clinic Limited 05676475 false 2024-08-01 2024-12-31 2024-12-31 The principal activity of the company is provision of opthalmic surgery and associated services. Digita Accounts Production Advanced 6.30.9574.0 true false 05676475 2024-08-01 2024-12-31 05676475 2024-12-31 05676475 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-12-31 05676475 core:RetainedEarningsAccumulatedLosses 2024-12-31 05676475 core:ShareCapital 2024-12-31 05676475 core:CurrentFinancialInstruments 2024-12-31 05676475 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 05676475 core:FurnitureFittings 2024-12-31 05676475 core:OfficeEquipment 2024-12-31 05676475 core:OtherPropertyPlantEquipment 2024-12-31 05676475 bus:SmallEntities 2024-08-01 2024-12-31 05676475 bus:AuditExemptWithAccountantsReport 2024-08-01 2024-12-31 05676475 bus:FilletedAccounts 2024-08-01 2024-12-31 05676475 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2024-12-31 05676475 bus:RegisteredOffice 2024-08-01 2024-12-31 05676475 bus:Director1 2024-08-01 2024-12-31 05676475 bus:Director4 2024-08-01 2024-12-31 05676475 bus:Director5 2024-08-01 2024-12-31 05676475 bus:Director6 2024-08-01 2024-12-31 05676475 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-08-01 2024-12-31 05676475 bus:PrivateLimitedCompanyLtd 2024-08-01 2024-12-31 05676475 bus:Agent1 2024-08-01 2024-12-31 05676475 core:FurnitureFittings 2024-08-01 2024-12-31 05676475 core:OfficeEquipment 2024-08-01 2024-12-31 05676475 core:OtherPropertyPlantEquipment 2024-08-01 2024-12-31 05676475 core:PlantMachinery 2024-08-01 2024-12-31 05676475 1 2024-08-01 2024-12-31 05676475 countries:England 2024-08-01 2024-12-31 05676475 2024-07-31 05676475 core:FurnitureFittings 2024-07-31 05676475 core:OfficeEquipment 2024-07-31 05676475 core:OtherPropertyPlantEquipment 2024-07-31 05676475 2023-08-01 2024-07-31 05676475 2024-07-31 05676475 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-07-31 05676475 core:RetainedEarningsAccumulatedLosses 2024-07-31 05676475 core:ShareCapital 2024-07-31 05676475 core:CurrentFinancialInstruments 2024-07-31 05676475 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 05676475 core:FurnitureFittings 2024-07-31 05676475 core:OfficeEquipment 2024-07-31 05676475 core:OtherPropertyPlantEquipment 2024-07-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05676475

Manchester Eye and Cosmetic Clinic Limited

Unaudited Filleted Financial Statements

for the Period from 1 August 2024 to 31 December 2024

 

Manchester Eye and Cosmetic Clinic Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 7

 

Manchester Eye and Cosmetic Clinic Limited

Company Information

Directors

Mr Imran Hakim

Dr Jonathan James Ross

Mr Luke Wren

Mr Sanjay Mantry

Registered office

Unit 317 India Mill Business Centre
Darwen
BB3 1AE

Accountants

Deans Accountants And Business Advisors Ltd 27 North Bridge Street
Hawick
Scottish Borders
TD9 9BD

 

DEANS

Chartered Accountants

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Manchester Eye and Cosmetic Clinic Limited for the Period Ended 31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Manchester Eye and Cosmetic Clinic Limited for the period ended 31 December 2024 as set out on pages 3 to 7 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants of Scotland (ICAS), we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/ethics/icas-code-of-ethics.

This report is made solely to the Board of Directors of Manchester Eye and Cosmetic Clinic Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Manchester Eye and Cosmetic Clinic Limited and state those matters that we have agreed to state to the Board of Directors of Manchester Eye and Cosmetic Clinic Limited, as a body, in this report in accordance with ICAS guidance (www.icas.com/accountsprep/guidance). To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Manchester Eye and Cosmetic Clinic Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Manchester Eye and Cosmetic Clinic Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Manchester Eye and Cosmetic Clinic Limited. You consider that Manchester Eye and Cosmetic Clinic Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the accounts of Manchester Eye and Cosmetic Clinic Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Deans Accountants And Business Advisors Ltd
27 North Bridge Street
Hawick
Scottish Borders
TD9 9BD

24 October 2025

 

Manchester Eye and Cosmetic Clinic Limited

(Registration number: 05676475)
Balance Sheet as at 31 December 2024

Note

2024
£

2024
£

Fixed assets

 

Tangible assets

4

111,606

124,099

Current assets

 

Stocks

5

126,777

103,291

Debtors

6

139,650

128,180

Cash at bank and in hand

 

258,715

250,669

 

525,142

482,140

Creditors: Amounts falling due within one year

7

(288,772)

(236,027)

Net current assets

 

236,370

246,113

Total assets less current liabilities

 

347,976

370,212

Provisions for liabilities

(27,212)

(30,861)

Net assets

 

320,764

339,351

Capital and reserves

 

Called up share capital

8

1,000

1,000

Retained earnings

319,764

338,351

Shareholders' funds

 

320,764

339,351

For the financial period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 24 October 2025 and signed on its behalf by:
 

.........................................
Mr Imran Hakim
Director

.........................................
Dr Jonathan James Ross
Director

.........................................
Mr Sanjay Mantry
Director

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2024 to 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Unit 317 India Mill Business Centre
Darwen
BB3 1AE
United Kingdom

These financial statements were authorised for issue by the Board on 24 October 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The accounts are presented in £GBP and are rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2024 to 31 December 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and Machinery

20% straight line

Fixtures and Fittings

15% straight line

Computer equipmnet

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving stocks. Cost in cludes all direct costs and an appropriate proportion of fixed and variable overheads. Work in progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2024 to 31 December 2024

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 15 (2024 - 24).

4

Tangible assets

Fixtures and fittings
£

Office equipment
£

Other tangible assets
 £

Total
£

Cost or valuation

At 1 August 2024

10,968

14,100

176,816

201,884

Additions

460

-

1,596

2,056

At 31 December 2024

11,428

14,100

178,412

203,940

Depreciation

At 1 August 2024

3,253

7,926

66,606

77,785

Charge for the period

630

1,131

12,788

14,549

At 31 December 2024

3,883

9,057

79,394

92,334

Carrying amount

At 31 December 2024

7,545

5,043

99,018

111,606

At 31 July 2024

7,867

6,022

110,210

124,099

5

Stocks

2024
£

2024
£

Other inventories

126,777

103,291

6

Debtors

Current

2024
£

2024
£

Trade debtors

118,282

85,336

Other debtors

21,368

42,844

 

139,650

128,180

7

Creditors

Creditors: amounts falling due within one year

2024
£

2024
£

Due within one year

Trade creditors

78,307

55,081

Taxation and social security

13,257

14,357

Other creditors

197,208

166,589

288,772

236,027

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Period from 1 August 2024 to 31 December 2024

8

Share capital

Allotted, called up and fully paid shares

2024

2024

No.

£

No.

£

Ordinary shares of £1 each

1,000

1,000

1,000

1,000

       

9

Parent and ultimate parent undertaking

The company's immediate parent is Crescere Holdings Limited, incorporated in England.